Announce Date | 04/22/2025 |
EPS Normalized Actual | $0.51 (Beat by $0.038) |
EPS GAAP Actual | $0.51 (Beat by $0.038) |
Revenue Actual | $6.427B |
Revenue Surprise | Beat by $6427M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.60337 |
EPS GAAP Estimate | $0.60337 |
Revenue Estimate | $7.263050248B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 3.25 | 11.91 | 3.16658 | 3.33089 | 1 |
Dec 2028 | 3.09 | 12.52 | 2.99311 | 3.19419 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.41 | 0.41 | 6.427B | 0.14% | 6427M |
FQ4 2024 (Dec 2024) | 1.19 | 1.19 | 7.364B | 7.18% | 7364M |
FQ3 2024 (Sep 2024) | 0.77 | 0.77 | 6.908B | 3.87% | 6908M |
FQ2 2024 (Jun 2024) | 0.58 | 0.58 | 7.139B | 11.54% | 7139M |
FQ1 2016 (Mar 2016) | 0 | 0 | 3.407B | 100% | 3407M |
FQ2 2016 (Jun 2016) | 0 | 0 | 3.322B | 100% | 3322M |
FQ4 2016 (Dec 2016) | -0.0023 | -0.0023 | 3.516B | 100% | 3516M |
FQ1 2024 (Mar 2024) | 0.46 | 0.46 | 6.418B | 10.94% | 6418M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.60337
Consensus Revenue Estimates
7.263050248B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.81 | -- | 0.77399 | 0.85699 | 8 |
FQ3 2027 (Sep 2027) | 0.74 | -- | 0.7071 | 0.78293 | 8 |
FQ2 2027 (Jun 2027) | 0.72 | -- | 0.68799 | 0.76177 | 8 |
FQ1 2027 (Mar 2027) | 0.63 | -- | 0.60199 | 0.66655 | 8 |
FQ4 2026 (Oct 2026) | 0.75897 | -- | 0.73395 | 0.7803 | 6 |
FQ3 2026 (Jul 2026) | 0.69746 | -- | 0.67447 | 0.71706 | 11 |
FQ2 2026 (Jun 2026) | 0.6633 | -- | 0.64103 | 0.68275 | 11 |
FQ1 2026 (Mar 2026) | 0.57705 | 28.95 | 0.55768 | 0.59397 | 6 |
FQ4 2025 (Oct 2025) | 0.67688 | -75.81 | 0.65457 | 0.6959 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 7.28B | -- | 7.03B | 7.6B | 9 |
FQ3 2027 (Sep 2027) | 6.96B | -- | 6.72B | 7.27B | 9 |
FQ2 2027 (Jun 2027) | 6.87B | -- | 6.63B | 7.17B | 9 |
FQ1 2027 (Mar 2027) | 6.42B | -- | 6.2B | 6.71B | 9 |
FQ4 2026 (Oct 2026) | 7.92B | -- | 7.72B | 8.09B | 6 |
FQ3 2026 (Jul 2026) | 7.59B | -- | 7.39B | 7.75B | 6 |
FQ2 2026 (Jun 2026) | 7.62B | -- | 7.42B | 7.79B | 6 |
FQ1 2026 (Mar 2026) | 7.05B | 8.83 | 6.87B | 7.21B | 12 |
FQ4 2025 (Oct 2025) | 7.53B | 2.14 | 7.33B | 7.69B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.41 | 0.41 | 100% | |
FQ4 2024 (Dec 2024) | 1.19 | 1.19 | 100% | |
FQ3 2024 (Sep 2024) | 0.77 | 0.77 | 100% | |
FQ2 2024 (Jun 2024) | 0.58 | 0.58 | 100% | |
FQ1 2016 (Mar 2016) | 0 | 0 | NAN% | |
FQ2 2016 (Jun 2016) | 0 | 0 | NAN% | |
FQ4 2016 (Dec 2016) | -0.0023 | -0.0023 | 100% | |
FQ1 2024 (Mar 2024) | 0.46 | 0.46 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $6.43B | $6427M | 100% |
FQ4 2024 (Dec 2024) | $0B | $7.36B | $7364M | 100% |
FQ3 2024 (Sep 2024) | $0B | $6.91B | $6908M | 100% |
FQ2 2024 (Jun 2024) | $0B | $7.14B | $7139M | 100% |
FQ1 2016 (Mar 2016) | $0B | $3.41B | $3407M | 100% |
FQ2 2016 (Jun 2016) | $0B | $3.32B | $3322M | 100% |
FQ4 2016 (Dec 2016) | $0B | $3.52B | $3516M | 100% |
FQ1 2024 (Mar 2024) | $0B | $6.42B | $6418M | 100% |